| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Correspondence to: D. Rozman, To whom correspondence should be addressed., damjana.rozman{at}mf.uni-lj.si (E-mail)
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
Lanosterol 14
-demethylase (CYP51) produces follicular fluid meiosis-activating sterol (FF-MAS), which is converted further to testis meiosis-activating sterol (T-MAS). MAS are intermediates in the cholesterol biosynthetic pathway, with the ability to trigger resumption of oocyte meiosis in vitro. In contrast to the liver, where pre- and post-MAS genes are upregulated coordinately at the level of transcription by a cholesterol feedback mechanism through sterol regulatory element-binding proteins (SREBP), regulation differs in the testis. Genes encoding pre-MAS enzymes [HMG-CoA synthase (SYN), HMG-CoA reductase (RED), farnesyl diphosphate synthase (FPP), squalene synthase (SS), and CYP51] are upregulated during sexual development of the testis, although not all genes are turned on at the same time. Furthermore, two post-MAS genes, C-4 sterol methyl oxidase and sterol 
7-reductase, are expressed at low levels and are not upregulated either in rat or human. This transcriptional discrepancy seems to be SREBP independent. Besides cAMP/cAMP-responsive element modulator, other unknown transcription factors control expression of individual cholesterogenic genes during spermatogenesis. HPLC analysis shows an 8-fold increase in T-MAS during development of rat testis whereas MAS is barely detectable in livers of the same animals.
We propose that the lack of a coordinate transcriptional control over the cholesterol biosynthetic pathway contributes importantly to overproduction of the signaling sterol T-MAS in testis. — Fon Tacer, K., T. B. Haugen, M. Baltsen, N. Debeljak, and D. Rozman. Tissue-specific transcriptional regulation of the cholesterol biosynthetic pathway leads to accumulation of testis meiosis-activating sterol (T-MAS). J. Lipid Res. 2002. 43: 82–89.
Supplementary key words:
cholesterol biosynthesis, cytochrome P450, lanosterol 14-demethylase, spermatogenesis and meiosis-activating sterol
|
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
Cholesterol is an essential constituent of cell membranes, with a crucial role in membrane function (1). It is also a precursor for bile acids and steroid hormones (2). Having indispensable roles on the one hand, while on the other hand being harmful in excess, the cholesterol level must be under precise control. Cholesterol homeostasis is maintained by a series of regulated pathways that control the acquisition of cholesterol from endogenous and exogenous sources, biosynthesis of cholesterol do novo, and elimination of cholesterol through conversion to bile acids and steroids (3). This homeostasis is regulated initially at the level of transcription by transcription factors of the sterol regulatory element-binding protein (SREBP) family (4). Mature SREBP is released from its membrane-bound precursor by a transport-dependent proteolytic cleavage (5). Cholesterol and oxysterols block this cleavage and regulate their own synthesis by a negative cholesterol feedback loop (6). In addition to cholesterol-dependent transcriptional regulation by SREBP, which is believed to be common to all involved genes, control at the posttranscriptional level also exists, at least in the case of HMG-CoA reductase (RED), which catalyzes the rate-limiting reaction of the mevalonate pathway (7). The quantity of RED is regulated at multiple levels (8), from transcription (9) to mRNA stabilization (10), translational efficiency (9) (11), reversible phosphorylation (12), and protein degradation (13).
In contrast to the liver, in haploid male germ cells (spermatids) lanosterol 14-demethylase (CYP51), one of the postlanosterol genes of cholesterol biosynthesis, seems to escape the SREBP-dependent regulation and is upregulated primarily by a cAMP/cAMP-responsive element modulator (CREM-
) (14). Spermatids develop in male puberty after the second meiotic division in the process of sexual maturation (15). Elevated CYP51 mRNA expression is observed in step 2–3 round spermatids, remaining high until step 14 (16), leading to elevated levels of CYP51 protein (17) in the same stages as the mRNA is observed. This suggests no delay in translation of CYP51 mRNA. The translated CYP51 protein is functional, showing a higher CYP51 activity in germ cells of sexually mature animals compared with prepubertal animals (16). Elevated mRNA (16) and protein (17) levels have been observed during male germ cell development also for squalene synthase (SS), which is a prelanosterol enzyme of cholesterol biosynthesis. Translation of this protein might be time-delayed because a rise in mRNA was observed earlier (pachytene spermatocytes), as the protein was immunodetected (step 3 round spermatids). Even if expression of some early cholesterogenic genes and the corresponding enzymes seems to be elevated during male germ cell development, male germ cells are not efficient in synthesizing cholesterol. The rates of [14C]acetate incorporation into cholesterol decreased in late pachynema remained low at all subsequent stages of meiosis, and were low in mature sperm (18). During capacitation, up to 40% of cholesterol is depleted from the plasma membrane of sperm cells in different mammalian species, because a relatively low cholesterol concentration in sperm cell membranes is prerequisite for successful fertilization (19). Thus, coupling the cholesterol efflux to activation of signaling events (20) (21) suggests low cholesterol synthesis in germ cells, whereas high expression of CYP51 and SS is observed (16) (22).
CYP51 is a member of the cytochrome P450 superfamily (http://drnelson.utmem.edu/CytochromeP450.html). It removes a C-32 methyl group at position 14 from lanosterol, forming follicular fluid meiosis-activating sterol (FF-MAS; 4,4-dimethyl-5-cholesta-8,14,24-triene-3ß-ol). FF-MAS is converted to testis meiosis-activating sterol (T-MAS; 4,4-di-methyl-5-cholesta-8,24-diene-3ß-ol) by sterol 14-reductase ( Fig 1A). MAS were isolated from the follicular fluid and testis, and have roles not only in cholesterol biosynthesis but also in signaling, with the ability to trigger resumption of oocyte meiosis (23) (24) (25). It is well established that intermediates of the prelanosterol portion of the pathway are involved in biological processes other than cholesterol synthesis (production of heme A and dolichol, farnesylation of proteins, etc.). The postlanosterol portion has been considered to be devoted exclusively to cholesterol (7). The discovery of FF-MAS and T-MAS in gonads pointed to the existence of additional roles also for postlanosterol intermediates (23). However, the postlanosterol portion of cholesterol biosynthesis is not well understood. The precise sequence of reactions is difficult to determine because of the broad substrate specificity of most postlanosterol enzymes (Fig 1A) (26) (27). Furthermore, sterol 14-reductase, a crucial gene required for T-MAS production, has not yet been characterized, whereas 24-reductase has been characterized (28).
|
We describe herein a detailed study of mRNA expression of pre- and postlanosterol cholesterogenic genes in the male gonad. We propose that differences in cholesterogenic gene expression contribute importantly to tissue-specific sterol profiles.
|
MATERIALS AND METHODS |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
HPLC assay of sterols
Sterols were separated by modification of a previously published method (29). Frozen testis was freeze-dried and lipids were extracted in 75% n-heptane-25% isopropanol (v/v). The organic phase was dried, reconstituted in mobile phase for HPLC straight-phase (SP) separation, and loaded onto a ChromSpher Si (5 µm, 250 x 4.6 mm; Varian, Palo Alto, CA) HPLC column running in (v/v) 99.65% n-heptane (BDH, Poole, UK)-0.35% isopropanol (J. T. Baker, Phillipsburg, NJ) at 1 ml/min. FF-MAS was read from SP chromatograms. The windows containing 4,4-dimethylsterols (window 2, 10 min–14 min), cholesterol and desmosterol (window 3, 23 min–26 min), and 5,7-ene sterols (window 4, 26 min 24 s–30 min) were collected automatically. Individual SP elution windows were dried and subjected to reversed-phase (RP) separation by reconstitution in acetonitrile and loading onto a LiChrospher RP (8.5 µm, 250 x 4.6 mm) HPLC column running in (v/v) 92.5% acetonitrile (Fisher Scientific, Pittsburgh, PA)-7.5% water at 1 ml/min, 40°C. All analytes were clearly identifiable on the basis of retention time (Fig 1D, panel a) and UV absorption at 200–300 nm (Fig 1D, panel b). Quantification was done by comparing the eluted peaks with runs of commercial standards lanosterol (L5768; Sigma, St. Louis, MO), 7-dehydrocholesterol (C3000; Steraloids, Newport, RI), desmosterol (C3150; Steraloids), and cholesterol (C6760; Steraloids) or laboratory standards [FF-MAS and T-MAS (29)]. Recovery was assessed by direct and transferred standards as explained previously (M. Baltsen, unpublished observations) and was between 70% and 130% for all analytes.
Preparation of probes
Mouse and human expressed sequence tag (EST) clones containing sequences related to late cholesterogenic genes were found after a BLAST search against the dbEST database (http://www. ncbi.nlm.nih.gov/blast). Clones containing potential mouse sterol 7-reductase (I.M.A.G.E. ID 875323, AA475208); human 7-reductase clone (I.M.A.G.E. ID 378803, AA683516), identical to human 7-reductase cDNA (AF034544); mouse sigma-1 receptor (S1R; I.M.A.G.E. ID 570543, AA108525), similar to the fungal ERG2 sterol 8,7-isomerase cDNA (M74037); and mouse C-4 sterol methyl oxidase (4,4MO; I.M.A.G.E. ID 22082, AA106129) have been selected and obtained from the RZPD/Reference Library Database (30). Plasmid DNA was isolated by standard procedures (31) and inserts were excised by a double restriction with NotI and EcoRI or EcoRI and XhoI (4,4MO). All EST clones were sequenced by an automatic sequencer and ABI PRISM BigDye Terminator Cycle Sequencing Ready Reaction Kit (Perkin-Elmer, Norwalk, CT). Plasmids containing partial mouse cDNA encoding RED (pmHMG-CoA Red/CRII) (32), HMG-CoA synthase (SYN) (pmHMG-CoA Syn/CRII) (32), and farnesyl diphosphate synthase (FPP) (pmFPP/CR2.1) (33) were received from the laboratory of J. L. Goldstein and M. S. Brown (Department of Molecular Genetics and Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX). Inserts were excised by double restriction with EcoRI.
Separation of human germ cells by elutrial centrifugation
Testicular material was obtained from organ donors in connection with donation of multiple organs after brain death according to a procedure approved by the local ethical committee. A cell suspension was prepared by treatment with trypsin and DNAse (34). Cells were further fractionated by centrifugal elutriation (35) into five fractions enriched in germ cells.
Northern analysis and quantification
Total RNA from SREBP transgenic mice liver was prepared as previously described (32) (36). Rat liver and testis were obtained from Sprague-Dawley rats (Møllegaard Laboratory, Ry, Denmark). Isolation of total RNA and Northern analysis were performed by standard procedures (31). 32P-labeled cDNA probes were prepared with a Prime-It II random primer labeling kit (Stratagene, La Jolla, CA). Filters were hybridized for 2 h with QuikHyb® hybridization solution (Stratagene) and washed twice for 15 min at room temperature under nonstringent conditions (0.1% SDS-2x SSC; 1x SSC is 0.15 M NaCl plus 0.015 M sodium citrate). To detect 28S RNA signal, filters were exposed overnight after nonstringent washing. To detect specific probe signal only a stringent wash with 0.1% SDS-2x SSC at 60°C for 5–30 min followed. Autoradiograms were scanned and quantified by densitometry, using Un-Scan-ITM gel version 5.1 (Silk Scientific, Orem, UT). Blots were normalized to signals generated by cyclophilin mRNA (membranes from liver of SREBP transgenic mice) or 28S rRNA (membranes from testis and germ cells).
|
RESULTS |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
Expression of cholesterogenic genes during development of rat testis
To investigate mRNA expression of cholesterogenic genes in maturing germ cells, Northern blots were made from whole testis of rats 6, 10, 15, 20, 25, 30, 40, 50, 60, and 70 days old. Expression of pre-MAS genes (SYN, RED, FPP, SS, and CYP51) is upregulated during the sexual development of rats ( Fig 2). For RED (37), FPP (38), and CYP51 (16) the increase is due to the appearance of testis-specific transcripts that were observed also for SYN (Fig 2C). Testis-specific transcripts of SYN, RED, and FPP arise earlier (30, 25, and 25 days, respectively; Fig 2A and Fig 2C) and increase gradually with time, in contrast to a sudden increase in the testis-specific transcript of CYP51 at day 40 (Fig 2C). This is in accordance with higher levels of CYP51 mRNA in germ cells from 44-day-old rats compared with 32-day-old rats (16). There is a discrepancy between expression levels of CYP51 and 4,4MO, an enzyme catalyzing the first step of conversion of T-MAS toward cholesterol. 4,4MO is also barely detectable in adult testis (Fig 2D). Similarly, 7-reductase expression is low and declines with age, being highest in 19-day-old testis, decreasing to 60% by day 32 and even more (63%) in 70-day-old testis (Fig 2B and Fig D). Expression of S1R does not change significantly with the age of the testis (Fig 2B).
|
To evaluate whether mouse EST clones that have been used as probes in expression studies of the developing rat testis indeed represent cholesterogenic genes, RNA from livers of wild-type and SREBP-1a (32), and SREBP-2 (36) transgenic mice was subjected to Northern analysis. CYP51 and three additional genes potentially involved in the postsqualene portion of cholesterol biosynthesis [4,4MO, S1R (potential sterol 8,7-isomerase) and 7-reductase] have been tested. Fig 3 shows that CYP51, 4,4MO, and 7-reductase are upregulated to a greater extent by SREBP-2 compared with SREBP-1. Such a pattern is characteristic for all genes involved in cholesterol biosynthesis (32) (36). S1R showed a weak increase of expression in SREBP-1a transgenic animals and an even lower increase in SREBP-2 transgenic livers, suggesting it is not a cholesterogenic gene.
|
Expression of late cholesterogenic genes during spermatogenesis in humans
Germ cell development in human seminiferous tubules occurs in a spiral arrangement with cells in different stages of development in close contact (15). In contrast to that, rodent germ cells mature in a wavelike fashion, allowing isolation of cells at a single stage (39). Because of these differences, it is important to determine whether phenomena observed during sexual maturation of rodents are also conserved in humans. We isolated RNAs from the germ cells of two organ donors, transferred them to a membrane, and monitored the relative expression levels of two late cholesterogenic genes, CYP51 and 7-reductase. Membranes were hybridized at the same time with both probes having the same specific activity (2 x 106 cpm/µg). Expression of human 7-reductase is up to 10-fold lower as compared with expression of CYP51 ( Fig 4), which is in accordance with results obtained in rats. A combination of in situ hybridization and Northern analysis studies of CYP51 mRNA expression during spermatogenesis in rats (16) and in mice (14) has indicated high level expression of the shortest CYP51 transcripts only in haploid germ cells (round and elongating spermatids). On the basis of similarities in the expression pattern of human, mouse, and rat CYP51 mRNAs and the conserved regulatory elements in the promoters of these genes (40), it is likely that the shortest CYP51 transcripts also appear in haploid germ cells of humans.
|
Quantification of cholesterol and of late intermediates of the cholesterol biosynthesis pathway in liver and testis of rats
Cholesterol and sterols of the postlanosterol part of the biosynthetic pathway were measured in the liver, as the main organ of cholesterol homeostasis, and in the testis, as the organ where the presence of T-MAS has been described (23) (24). As seen in Fig 1B, cholesterol is the main product in livers of rats at three different ages. The amount of cholesterol does not vary significantly with the age of normally fed animals. Intermediates of cholesterol biosynthesis are barely detectable in the liver. In contrast to the liver, the amount of testis cholesterol (Fig 1C) decreased by up to 43% with increasing animal age and sexual maturation of the testis, from 2,415 ppm in 19-day-old rats, to 1,382 and 1,544 ppm in 32- and 70-day-old rats, respectively. Detection of the postlanosterol intermediate T-MAS in testis presents another difference from the liver. An 8-fold increase in T-MAS is observed with increasing age, being 6.1 ppm in 19-day-old rats, 40.3 ppm in 32-day-old rats, and 49.0 ppm in 70-day-old rats. Other intermediates were observed in much lower amounts, suggesting that T-MAS is indeed the dominant precholesterol sterol of the male gonad (Fig 1C).
|
DISCUSSION |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
Our data provide evidence that male germ cells lack a coordinate transcriptional control over the cholesterol biosynthetic pathway. The tissue-specific expression of pre-MAS and post-MAS genes is the primary regulatory checkpoint that leads to accumulation of the meiosis-signaling sterol T-MAS during maturation of male germ cells. It seems possible that transcription factors of the SREBP family are not involved in upregulation of cholesterogenic genes in male germ cells. In the liver, where regulation of cholesterol homeostasis takes place, a coordinate SREBP-dependent transcriptional upregulation of all involved genes does exist (33) (36). In addition to early cholesterogenic genes (32) (36), CYP51, 4,4MO, and 7-reductase are also upregulated primarily by SREBP-2 and to a lower extent by SREBP-1 (Fig 3). In both liver and epidermis (41), regulation of cholesterol biosynthesis seems to follow the cholesterol feedback loop. No coordinate transcriptional upregulation is observed in male germ cells, where mobility shift fails to show the presence of SREBP in nuclear extracts (14). In mature 70-day-old rat testis, the expression of early cholesterogenic genes that represent steps in cholesterol biosynthesis leading to synthesis of MAS (SYN, RED, FPP, SS, and CYP51; Fig 2) is much higher as compared with expression of late cholesterogenic genes encoding enzymes responsible for bioconversion of MAS toward cholesterol (4,4MO and 7-reductase). A direct comparison of CYP51 and 7-reductase expression levels in human spermatogenesis shows the same discrepancy (Fig 4). In addition to differences in expression levels, the trend in expression of pre-MAS and post-MAS genes differs during maturation of the testis, that is, expression of pre-MAS genes is upregulated whereas expression of post-MAS genes is unchanged or even downregulated with increasing age of the animals (Fig 2). As in germ cells, transcriptional regulation of cholesterol biosynthesis also seems to be independent of cholesterol levels in endocrine tissues under conditions of increased steroid hormone synthesis. Orphan nuclear receptor steroidogenic factor 1 is able to overcome the negative cholesterol feedback loop and upregulates transcription of SYN also in the cholesterol well-fed state (42).
The SREBP-independent transcriptional upregulation of genes involved in cholesterol homeostasis acquired the term "sterol-independent," but molecular mechanisms leading to such regulation seem to differ with each individual gene. Nonsterol stimuli, such as onkostatin M (43), and phorbol esters and cycloheximide (44), induce transcription of the LDL receptor gene through distinct promoter elements that do not require the presence of SREBP. Cholesterogenic CYP51 is upregulated in male germ cells (16) by a CREM--dependent mechanism (14). CREM- is a master activator of cAMP-dependent gene expression in haploid male germ cells (45). However, CREM- is not a master activator of cholesterogenic gene expression in spermatogenesis. In addition to CYP51, CREM- might upregulate SYN and FPP, which both show increased expression on days 30–40 of testis development, when haploid germ cells appear (Fig 2A) (15), but does not seem to control RED and SS expression, which are increased already at the spermatocyte stage (Fig 2A) or are not diminished in testis of CREM-/- animals (14). In addition, CREM- does not control 4,4MO and 7-reductase, which remain expressed at low levels during testis development (Fig 2B).
A lack of coordinate transcriptional regulation and a discrepancy between pre-MAS and post-MAS gene expression indicate that the primary role of male germ cells may not be to synthesize cholesterol but to produce MAS. The HPLC profile shows a correlation between the quantity of sterol intermediates in maturing rat testis and the expression level of genes encoding enzymes of the cholesterol biosynthetic pathway. Increasing amounts of T-MAS are detected with increasing testis age, being 8-fold higher in sexually mature, 70-day-old rats as compared with immature, 19-day-old rats. T-MAS is able to trigger meiotic progression of the oocyte ex vivo (23) (46) but the in vivo role of T-MAS synthesized by testis remains to be demonstrated. Most mature spermatids of the testis have the potential to synthesize MAS in situ because of the expression of the CYP51 system in the acrosome (17). However, an MAS-specific receptor has not yet been found (47). Data suggest that the MAS receptor is not a nuclear-type receptor but rather an oocyte plasma membrane-associated protein with high affinity for FF-MAS (48), and that a G protein-coupled mechanism is involved in MAS signaling (46).
Our data suggest that accumulation of T-MAS is achieved primarily by regulation at the level of transcription, where genes encoding pre-MAS enzymes are upregulated during male germ cell development and genes encoding post-MAS enzymes are not. We propose that the highly expressed CYP51 mRNA that is translated into the functionally active lanosterol 14-demethylase protein (16) (17) produces FF-MAS, which is readily converted to T-MAS by the sterol 14-reductase. The sterol 14-reductase gene, which is not yet characterized in mammals, is likely highly expressed in the testis. The absence of immediate metabolites of T-MAS in the testis suggests that insufficient amounts of the 4,4MO enzyme are produced from the observed low level of 4,4MO mRNA. Besides transcriptional regulation, regulation at posttranscriptional levels, such as enzyme inhibition (49) (50), may also be important in the production of MAS. Development of a tissue-specific transcriptional regulatory system to produce a cholesterol biosynthetic pathway intermediate in the male gonad suggests that T-MAS has an important physiological role. It remains to be elucidated whether T-MAS contributes to completion of the second meiotic division of the oocyte also in vivo or is involved in other, yet unknown signaling processes.
|
FOOTNOTES |
|---|
1 An article showing that the entire pathway of cholesterol synthesis is induced by SREBP in the liver has been published during the time that our manuscript was being revised (Sakakura, Y., H. Shimano, H. Sone, A. Takahashi, K. Inoue, N. Toyoshima, S. Suzuki, and N. Yamada. 2001. Biochem. Biophys. Res. Commun. 286: 176–183). 
|
ACKNOWLEDGMENTS |
|---|
This work was supported by grants J1-1380, SLO-USA 0002, and P1-0527 from the Ministry of Science of Slovenia, by FIRCA/NIH grant 1 RO3 TW01174-01 and ICGEB grant CRP/SLO 00-01, and by the Danish Research Council grants 9601015 and 9700832. K.F.T. and N.D. are supported by fellowships from the Ministry of Education Science and sports of Slovenia.We sincerely thank Drs. Jay D. Horton, Michael S. Brown, and Joseph L. Goldstein (Department of Molecular Genetics and Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX) for help in accumulating data about SREBP-1a and SREBP-2 transgenic mice. The skillful technical assistance of Mrs. Trine Henrichen and Mrs. Turid Vollen (Andrology Laboratory Department of Gynecology and Obstetrics, University of Oslo) is greatly appreciated. Many thanks to Dr. M. R. Waterman (Vanderbilt University, Nashville, TN) for helpful discussion and evaluation of the manuscript.
Manuscript received April 19, 2001; and in revised form September 10, 2001
Abbreviations:
CREM-, cAMP-responsive element modulator; EST, expressed sequence tag; FSH, follicle-stimulating hormone; FDS MAS, meiosis-activating sterol; FPP, farnesyl disphosphate synthase; RED, HMG-CoA reductase; SREBP, sterol regulatory element-binding protein; SS, squalene synthase; SYN, HMG-CoA sythase; T-MAS, testis meiosis-activating sterol
|
REFERENCES |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
-demethylase (CYP51) in spermatids. Mol. Endocrinol. 13:1951-1962-demethylase (CYP51) and the synthesis of oocyte meiosis-activating sterols in postmeiotic germ cells of male rats. Endocrinology. 139:2314-2321[Abstract/Full Text].
, G., Parvinen, M., Bellamine, A., Harwood, H. J., Jr., Ku, W. W., Waterman, M. R., Rozman, D. 2000. Lanosterol 14-de-methylase (CYP51), NADPH-cytochrome P450 reductase and squalene synthase in spermatogenesis: late spermatids of the rat express proteins needed to synthesize follicular fluid meiosis activating sterol. J. Endocrinol. 166:463-474-demethylase, a cytochrome P450 whose expression is regulated by oxysterols. Arch. Biochem. Biophys. 329:73-8124-reductase. Biochem. J. 326:609-616[Medline][Medline].24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis. Am. J. Hum. Genet. 69:685-694[Medline].-demethylase (CYP51), a new member of the evolutionarily most conserved cytochrome P450 family. Arch. Biochem. Biophys. 379:37-45[Abstract][Medline].
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  K. F. Tacer, D. Kuzman, M. Seliskar, D. Pompon, and D. Rozman TNF-{alpha} interferes with lipid homeostasis and activates acute and proatherogenic processes Physiol Genomics, October 19, 2007; 31(2): 216 - 227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Suzuki, K. Kiyosue, S. Hazama, A. Ogura, M. Kashihara, T. Hara, H. Koshimizu, and M. Kojima Brain-Derived Neurotrophic Factor Regulates Cholesterol Metabolism for Synapse Development J. Neurosci., June 13, 2007; 27(24): 6417 - 6427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fink, J. Acimovic, T. Rezen, N. Tansek, and D. Rozman Cholesterogenic Lanosterol 14{alpha}-Demethylase (CYP51) Is an Immediate Early Response Gene Endocrinology, December 1, 2005; 146(12): 5321 - 5331. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ishikawa, K. Hwang, D. Lazzarino, and P. L. Morris Sertoli Cell Expression of Steroidogenic Acute Regulatory Protein-Related Lipid Transfer 1 and 5 Domain-Containing Proteins and Sterol Regulatory Element Binding Protein-1 Are Interleukin-1{beta} Regulated by Activation of c-Jun N-Terminal Kinase and Cyclooxygenase-2 and Cytokine Induction Endocrinology, December 1, 2005; 146(12): 5100 - 5111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wang, J. T. San Agustin, G. B. Witman, and D. L. Kilpatrick Novel Role for a Sterol Response Element Binding Protein in Directing Spermatogenic Cell-Specific Gene Expression Mol. Cell. Biol., December 15, 2004; 24(24): 10681 - 10688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cotman, D. Jezek, K. F. Tacer, R. Frangez, and D. Rozman A Functional Cytochrome P450 Lanosterol 14{alpha}-Demethylase CYP51 Enzyme in the Acrosome: Transport through the Golgi and Synthesis of Meiosis-Activating Sterols Endocrinology, March 1, 2004; 145(3): 1419 - 1426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Rodriguez, B. Raposo, J. Martinez-Gonzalez, V. Llorente-Cortes, G. Vilahur, and L. Badimon Modulation of ERG25 expression by LDL in vascular cells Cardiovasc Res, April 1, 2003; 58(1): 178 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Wang, F. Liu, C. F. Millette, and D. L. Kilpatrick Expression of a Novel, Sterol-Insensitive Form of Sterol Regulatory Element Binding Protein 2 (SREBP2) in Male Germ Cells Suggests Important Cell- and Stage-Specific Functions for SREBP Targets during Spermatogenesis Mol. Cell. Biol., December 15, 2002; 22(24): 8478 - 8490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Halder, M. Fink, M. R. Waterman, and D. Rozman A cAMP-Responsive Element Binding Site Is Essential for Sterol Regulation of the Human Lanosterol 14{alpha}-Demethylase Gene (CYP51) Mol. Endocrinol., August 1, 2002; 16(8): 1853 - 1863. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Soccio, R. M. Adams, M. J. Romanowski, E. Sehayek, S. K. Burley, and J. L. Breslow The cholesterol-regulated StarD4 gene encodes a StAR-related lipid transfer protein with two closely related homologues, StarD5 and StarD6 PNAS, May 14, 2002; 99(10): 6943 - 6948. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||
